For the Inventor, By the Inventor

Enter assignee name

Pittsburgh, PA, United States of America

Duquesne University of the Holy Spirit

USPTO Granted Patents = 71

CIPO Patents = 9

EPO Patents = 10

Trademarks = 21

Forward Citations = 63

Loading Chart...

Loading Chart...

36 inventors (with patents filed for the assignee):

Aleem Gangjee (49 out of 86 patents)

Larry H Matherly (8 out of 14 patents)

Paula A Witt-Enderby (4 out of 4 patents)

4. Vicki L Davis (4 out of 4 patents)

5. Michael C Ryan (3 out of 50 patents)

6. Robert Hugh Edgar (3 out of 3 patents)

7. John D Hempel (3 out of 3 patents)

8. John Andrew Viator (3 out of 3 patents)

9. Patrick Juola (3 out of 4 patents)

10. Ellen S Gawalt (3 out of 9 patents)

11. John Alston Kellum (3 out of 26 patents)

12. James Orlo Overly (2 out of 2 patents)

13. John Isaac Noecker, Jr (2 out of 2 patents)

14. Christine Gray (2 out of 2 patents)

15. Kenneth A McGowan (2 out of 12 patents)

Core Competencies:

Antitumor Agents

Pyrimidine Compounds

Bacteriophage Detection

Tyrosine Kinase Inhibitors

Microtubule Targeting Agents

Folate Receptor Inhibitors

Biometric Identification

Artificial Bone Compositions

Cyclopenta Pyrimidines

Antimitotic Activity

SHMT2 Inhibitors

Aryl Sulfonyl Isonitriles

71 patents: Sort by Forward Citations

1. 11897886 - Pyrazolo[4,3-d]pyrimidines as antitumor agents (2024-02-13),

2. 11840539 - Substituted pyrrolo,-furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof (2023-12-12),

3. 11629370 - Detection of bacteria using bacteriophage (2023-04-18),

4. 11618758 - Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient (2023-04-04),

5. 11605055 - Authorship technologies (2023-03-14),

6. 11572363 - Substituted bicyclic pyrimidine compounds with tubulin and multiple receptor inhibition (2023-02-07),

7. 11384084 - First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agents (2022-07-12),

8. 11124520 - Cyclopenta[d]pyrimidines and substituted cyclopenta[d]pyrimidines as antitubulin and microtubule targeting agents, monocyclic pyrimidines as tubulin inhibitors, and pyrrolopyrimidines as targeted antifolates and tubulin and multiple receptor tyrosine kinase inhibitor and antitumor agents (2021-09-21),

9. 11111252 - Pyrimidine compounds and pyrimido indole compounds and methods of use (2021-09-07),

10. 11091500 - Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof (2021-08-17),

11. 11078214 - Monocyclic thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of same (2021-08-03),

12. 11053252 - Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the same (2021-07-06),

13. 11001595 - Pyrimidine compounds and pyrimido indole compounds and methods of use (2021-05-11),

14. 10961557 - Detection of bacteria using bacteriophage (2021-03-30),

15. 10947246 - Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof (2021-03-16),

Duquesne University of the Holy Spirit is a Catholic university located in Pittsburgh, Pennsylvania. Established in 1878, it offers a wide range of undergraduate, graduate, and professional programs across various disciplines. The university is committed to providing an education rooted in the Spiritan tradition, emphasizing academic excellence, ethical leadership, and service to others. Visit their website for more information and to explore their academic offerings.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

71 Patents

#35 in Pittsburgh, PA

#193 in Pennsylvania

#4,995 in US

#10,223 in the World

Pittsburgh, PA, United States of America

Duquesne University of the Holy Spirit

Forward Citations = 63

36 inventors:

Aleem Gangjee (49 out of 86 patents)

Larry H Matherly (8 out of 14 patents)

Paula A Witt-Enderby (4 out of 4 patents)

4. Vicki L Davis (4 out of 4 patents)

5. Michael C Ryan (3 out of 50 patents)

Please report any incorrect information to support@idiyas.com

Loading…